Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nuclear Medicine and Radio Pharmaceuticals market report explains the definition, types, applications, major countries, and major players of the Nuclear Medicine and Radio Pharmaceuticals market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GE Healthcare
Esaote
TriFoil Imaging
Hitachi
Biosensors International Group, Ltd
Philips Healthcare
Shimadzu
Carestream
Toshiba
Siemens Healthcare
By Type:
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
By End-User:
Diagnostic Applications: SPECT, PET
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Nuclear Medicine and Radio Pharmaceuticals Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Nuclear Medicine and Radio Pharmaceuticals Outlook to 2028- Original Forecasts
-
2.2 Nuclear Medicine and Radio Pharmaceuticals Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Nuclear Medicine and Radio Pharmaceuticals Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Nuclear Medicine and Radio Pharmaceuticals Market- Recent Developments
-
6.1 Nuclear Medicine and Radio Pharmaceuticals Market News and Developments
-
6.2 Nuclear Medicine and Radio Pharmaceuticals Market Deals Landscape
7 Nuclear Medicine and Radio Pharmaceuticals Raw Materials and Cost Structure Analysis
-
7.1 Nuclear Medicine and Radio Pharmaceuticals Key Raw Materials
-
7.2 Nuclear Medicine and Radio Pharmaceuticals Price Trend of Key Raw Materials
-
7.3 Nuclear Medicine and Radio Pharmaceuticals Key Suppliers of Raw Materials
-
7.4 Nuclear Medicine and Radio Pharmaceuticals Market Concentration Rate of Raw Materials
-
7.5 Nuclear Medicine and Radio Pharmaceuticals Cost Structure Analysis
-
7.5.1 Nuclear Medicine and Radio Pharmaceuticals Raw Materials Analysis
-
7.5.2 Nuclear Medicine and Radio Pharmaceuticals Labor Cost Analysis
-
7.5.3 Nuclear Medicine and Radio Pharmaceuticals Manufacturing Expenses Analysis
8 Global Nuclear Medicine and Radio Pharmaceuticals Import and Export Analysis (Top 10 Countries)
-
8.1 Global Nuclear Medicine and Radio Pharmaceuticals Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Nuclear Medicine and Radio Pharmaceuticals Export by Region (Top 10 Countries) (2017-2028)
9 Global Nuclear Medicine and Radio Pharmaceuticals Market Outlook by Types and Applications to 2022
-
9.1 Global Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Consumption and Growth Rate (2017-2022)
-
9.2 Global Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostic Applications: SPECT, PET Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Nuclear Medicine and Radio Pharmaceuticals Market Analysis and Outlook till 2022
-
10.1 Global Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.2.2 Canada Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.2.3 Mexico Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.2 UK Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.3 Spain Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.4 Belgium Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.5 France Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.6 Italy Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.7 Denmark Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.8 Finland Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.9 Norway Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.10 Sweden Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.11 Poland Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.12 Russia Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.3.13 Turkey Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.2 Japan Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.3 India Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.4 South Korea Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.5 Pakistan Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.6 Bangladesh Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.7 Indonesia Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.8 Thailand Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.9 Singapore Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.10 Malaysia Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.11 Philippines Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.4.12 Vietnam Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.5.2 Colombia Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.5.3 Chile Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.5.4 Argentina Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.5.5 Venezuela Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.5.6 Peru Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.5.7 Puerto Rico Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.5.8 Ecuador Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.6.2 Kuwait Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.6.3 Oman Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.6.4 Qatar Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.6.5 Saudi Arabia Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.6.6 United Arab Emirates Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.7.2 South Africa Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.7.3 Egypt Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.7.4 Algeria Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
-
10.8.2 New Zealand Nuclear Medicine and Radio Pharmaceuticals Consumption (2017-2022)
11 Global Nuclear Medicine and Radio Pharmaceuticals Competitive Analysis
-
11.1 GE Healthcare
-
11.1.1 GE Healthcare Company Details
-
11.1.2 GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.1.4 GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Esaote
-
11.2.1 Esaote Company Details
-
11.2.2 Esaote Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Esaote Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.2.4 Esaote Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 TriFoil Imaging
-
11.3.1 TriFoil Imaging Company Details
-
11.3.2 TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.3.4 TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Hitachi
-
11.4.1 Hitachi Company Details
-
11.4.2 Hitachi Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Hitachi Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.4.4 Hitachi Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Biosensors International Group, Ltd
-
11.5.1 Biosensors International Group, Ltd Company Details
-
11.5.2 Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.5.4 Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Philips Healthcare
-
11.6.1 Philips Healthcare Company Details
-
11.6.2 Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.6.4 Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Shimadzu
-
11.7.1 Shimadzu Company Details
-
11.7.2 Shimadzu Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Shimadzu Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.7.4 Shimadzu Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Carestream
-
11.8.1 Carestream Company Details
-
11.8.2 Carestream Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Carestream Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.8.4 Carestream Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Toshiba
-
11.9.1 Toshiba Company Details
-
11.9.2 Toshiba Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Toshiba Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.9.4 Toshiba Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Siemens Healthcare
-
11.10.1 Siemens Healthcare Company Details
-
11.10.2 Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
11.10.4 Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Nuclear Medicine and Radio Pharmaceuticals Market Outlook by Types and Applications to 2028
-
12.1 Global Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Diagnostic Applications: SPECT, PET Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Nuclear Medicine and Radio Pharmaceuticals Market Analysis and Outlook to 2028
-
13.1 Global Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.2.2 Canada Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.2.3 Mexico Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.2 UK Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.3 Spain Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.4 Belgium Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.5 France Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.6 Italy Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.7 Denmark Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.8 Finland Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.9 Norway Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.10 Sweden Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.11 Poland Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.12 Russia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.3.13 Turkey Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.2 Japan Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.3 India Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.4 South Korea Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.8 Thailand Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.9 Singapore Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.11 Philippines Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.5.2 Colombia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.5.3 Chile Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.5.4 Argentina Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.5.6 Peru Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.6.3 Oman Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.6.4 Qatar Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.7.2 South Africa Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.7.3 Egypt Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.7.4 Algeria Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Nuclear Medicine and Radio Pharmaceuticals
-
Figure of Nuclear Medicine and Radio Pharmaceuticals Picture
-
Table Global Nuclear Medicine and Radio Pharmaceuticals Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Nuclear Medicine and Radio Pharmaceuticals Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Applications: SPECT, PET Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications Consumption and Growth Rate (2017-2022)
-
Figure Global Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)
-
Table North America Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)
-
Figure United States Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Canada Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Mexico Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table Europe Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)
-
Figure Germany Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure UK Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Spain Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Belgium Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure France Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Italy Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Denmark Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Finland Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Norway Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Sweden Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Poland Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Russia Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Turkey Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table APAC Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)
-
Figure China Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Japan Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure India Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Thailand Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Singapore Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Philippines Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table South America Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)
-
Figure Brazil Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Colombia Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Chile Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Argentina Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Peru Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table GCC Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)
-
Figure Bahrain Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Oman Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Qatar Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table Africa Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)
-
Figure Nigeria Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure South Africa Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Egypt Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Algeria Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table Oceania Nuclear Medicine and Radio Pharmaceuticals Consumption by Country (2017-2022)
-
Figure Australia Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Nuclear Medicine and Radio Pharmaceuticals Consumption and Growth Rate (2017-2022)
-
Table GE Healthcare Company Details
-
Table GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table GE Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table Esaote Company Details
-
Table Esaote Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Esaote Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table Esaote Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table TriFoil Imaging Company Details
-
Table TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table TriFoil Imaging Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table Hitachi Company Details
-
Table Hitachi Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hitachi Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table Hitachi Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table Biosensors International Group, Ltd Company Details
-
Table Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table Biosensors International Group, Ltd Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table Philips Healthcare Company Details
-
Table Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table Philips Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table Shimadzu Company Details
-
Table Shimadzu Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shimadzu Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table Shimadzu Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table Carestream Company Details
-
Table Carestream Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Carestream Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table Carestream Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table Toshiba Company Details
-
Table Toshiba Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Toshiba Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table Toshiba Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Table Siemens Healthcare Company Details
-
Table Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Main Business and Markets Served
-
Table Siemens Healthcare Nuclear Medicine and Radio Pharmaceuticals Product Portfolio
-
Figure Global Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Applications: SPECT, PET Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)
-
Table North America Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure United States Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Germany Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure China Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Brazil Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast by Country (2022-2028)
-
Figure Australia Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Nuclear Medicine and Radio Pharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
